Helmholtz Zentrum München - German Research Center for Environmental Health, Institute of Molecular Immunology (IMI)
Wissenschaft wird von Menschen gemacht
(W. Heisenberg, Der Teil und das Ganze)
Institute of Molecular Immunology
The research activities of the Institute of Molecular Immunology focus on the boundary between hematology, immunology, oncology and transplantation biology. This is where concepts are developed for modulating the immune system by means of cell and molecular biological methods. New strategies are investigated for immunotherapy and gene therapy for cancer, autoimmune diseases and graft rejections.
Working groups
- Dendritic cell – T cell interactions
Head: Prof. Dr. Dolores J. Schendel
Principal investigator: Dr. rer. nat. Bernhard Frankenberger - Antitumour immunity and adoptive T-cell therapy in renal cell carcinoma
Head: PD Dr. rer. nat. Elfriede Nößner - Regulation of innate and adaptive immunity as the basis for new approaches of immunotherapy
Head: Prof. Dr.med. Ralph Mocikat - Molecular programming of T-cell tolerance
Head: Dr. rer .nat. Vigo Heissmeyer - Core facility for generation of monoclonal antibodies and cell sorting
Head: Dr. med. Elisabeth Kremmer
Principal investigators: Dr. rer. biol. hum. Joachim W. Ellwart, Dr. rer. nat. Josef Mysliwietz - GMP process development for cellular immunotherapies
Head: Iris Bigalke
- Immune Monitoring Platform
Head: Prof. Dr. Dolores J. Schendel
Principal investigators: Prof. Dr. Ulrike Protzer, Prof. Dr. Dirk Busch - Clinical Cooperation Group „Hyperthermia“
Head: Prof. Dr. med. Rolf Issels - Clinical Cooperation Group “Hematopoietic stem cell transplantation”
Head: Prof. Dr. med. Hans-Jochem Kolb
Kolb retired in April 2010 and KKG ended in Sept. 2010 - Platform for preclinical studies
Head: Prof. Dr. med. Ralph Mocikat